“Diagnosis of an individual at risk for Alzheimer’s disease has been the biggest challenge in the field of Alzheimer’s disease and the Altoida, digital biomarker technology will provide us with an innovative tool to detect the onset of Alzheimer’s disease in a reliable and gamified fashion.” – Dr. Namrata Das MD, MPH, Center for BrainHealth, The University of Texas at Dallas, who has been studying Altoida’s technology for the past year.